Authors

• Sophia B. Georghiou (ORCID: https://orcid.org/0000-0003-0099-903X)
• Reinout van Crevel
• Anna M. Mandalakas (ORCID: https://orcid.org/0000-0002-8091-3509)
• Mikashmi Kohli (ORCID: https://orcid.org/0000-0002-7402-5791)
• Lieven Stuyver (ORCID: https://orcid.org/0000-0001-7818-9390)
• Ursula Panzner
• Andrew R. DiNardo (ORCID: https://orcid.org/0000-0001-5990-6470)
• Norbert Hittel
• Sami Taghlabi
• Danna Carrero Longlax
• Anca Vasiliu
• Rob J. W. Arts
• Christoph Lange
• Wilbert Sabiiti
• Morten Ruhwald
• Collins Musia
• Stephen H. Gillespie

Institutions

• Andrews University (US)
• Janssen (Belgium) (BE)
• Radboud University Nijmegen (NL)
• Angkor Hospital for Children (KH)
• University Medical Center (US)
• Radboud University Medical Center (NL)
• University of Oxford (GB)
• Novel (Germany) (DE)
• German Center for Infection Research (DE)
• Janssen (United Kingdom) (GB)
• Research Center Borstel - Leibniz Lung Center (DE)
• Texas Children's Hospital (US)
• University of Lübeck (DE)

Publication Details

Journal

Frontiers in Antibiotics

Published

2026-03-02

DOI

https://doi.org/10.3389/frabi.2025.1748877

Primary Topic

Tuberculosis Research and Epidemiology

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Deutsches Zentrum für Infektionsforschung
• European Federation of Pharmaceutical Industries and Associations
• European Commission
• Bundesministerium für Bildung und Forschung
• Ludwig-Maximilians-Universität München